| scholarly article | Q13442814 |
| P50 | author | Chun-Liang Chen | Q92465302 |
| P2093 | author name string | Andrei Radulescu | |
| Hong-yi Zhang | |||
| Gail E. Besner | |||
| Jacob K. Olson | |||
| Amanda K. Darbyshire | |||
| P2860 | cites work | A Heparin-Binding Growth Factor Secreted by Macrophage-Like Cells That Is Related to EGF | Q24319855 |
| N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration | Q24535534 | ||
| Diphtheria Toxin | Q28268924 | ||
| p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades | Q28362225 | ||
| Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity | Q28631171 | ||
| Heparin binding epidermal growth factor-like growth factor and PD169316 prevent apoptosis in mouse embryonic stem cells | Q33887579 | ||
| Diphtheria toxin binds to the epidermal growth factor (EGF)-like domain of human heparin-binding EGF-like growth factor/diphtheria toxin receptor and inhibits specifically its mitogenic activity. | Q34317276 | ||
| Ischemia-reperfusion injury of the intestine and protective strategies against injury | Q35916693 | ||
| Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways. | Q35994805 | ||
| Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice | Q36808906 | ||
| Role of EGFR transactivation in preventing apoptosis in Pseudomonas aeruginosa-infected human corneal epithelial cells | Q37151646 | ||
| Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes | Q37289601 | ||
| Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice | Q37367909 | ||
| Protection against hemorrhagic shock in mice genetically deficient in poly(ADP-ribose)polymerase | Q37429030 | ||
| Epithelial tight junctions in intestinal inflammation | Q37524296 | ||
| Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancer. | Q38358504 | ||
| Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis | Q40033966 | ||
| Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor | Q40614096 | ||
| Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo | Q40633877 | ||
| Isolation and characterization of a macrophage-derived heparin-binding growth factor. | Q40647293 | ||
| Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia/reperfusion injury | Q40648030 | ||
| Gut ischaemia | Q40723965 | ||
| Heparin-binding epidermal growth factor-like growth factor protects rat intestine from ischemia/reperfusion injury | Q40786052 | ||
| Heparin-binding epidermal growth factor–like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis | Q42093441 | ||
| Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury | Q42726930 | ||
| Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate | Q42769676 | ||
| Liver regeneration in heparin-binding EGF-like growth factor transgenic mice after partial hepatectomy | Q44337885 | ||
| Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats | Q46892677 | ||
| Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. | Q52118607 | ||
| Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. | Q53630464 | ||
| HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. | Q54650079 | ||
| HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. | Q54795142 | ||
| Heparin-Binding EGF-Like Growth Factor Down Regulates Proinflammatory Cytokine-Induced Nitric Oxide and Inducible Nitric Oxide Synthase Production in Intestinal Epithelial Cells | Q57450777 | ||
| Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal | Q71537631 | ||
| Upregulation of endogenous heparin-binding EGF-like growth factor and its role as a survival factor in skeletal myotubes | Q73047425 | ||
| Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury | Q73114692 | ||
| Heparin-binding EGF-like growth factor preserves mesenteric microcirculatory blood flow and protects against intestinal injury in rats subjected to hemorrhagic shock and resuscitation | Q80774830 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemorrhagic shock | Q2964243 |
| resuscitation | Q5491454 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 276-283 | |
| P577 | publication date | 2010-10-20 | |
| P1433 | published in | Surgery | Q15731526 |
| P1476 | title | Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation | |
| P478 | volume | 149 |
| Q39513204 | Creating a flexible multiple microRNA expression vector by linking precursor microRNAs |
| Q54458115 | HB-EGF promotes intestinal restitution by affecting integrin-extracellular matrix interactions and intercellular adhesions. |
| Q35141090 | HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity |
| Q37009351 | Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury |
| Q38380575 | Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects |
| Q42325850 | Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis |
| Q36614045 | Heparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis |
Search more.